Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
基本信息
- 批准号:8466024
- 负责人:
- 金额:$ 3.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAttenuatedBlood GlucoseCatalytic DomainComplexDataDefectDevelopmentDiabetes MellitusDistalDoseEpidemicExerciseFiberFundingGLUT4 geneGTPase-Activating ProteinsGene TransferGeneticGoalsHealthHealth BenefitHumanIndividualInsulinInsulin ResistanceLearningLinkLipidsMAPK8 geneMeasuresMediatingMediator of activation proteinMethodsMuscleMuscle FibersNon-Insulin-Dependent Diabetes MellitusObesityPhosphorylationPhosphotransferasesPhysiologicalPost-Translational Protein ProcessingProtein DephosphorylationProtein IsoformsProtein SProtein phosphatasePublic HealthPublicationsRattusRegulationReportingResearchRoleSecondary toSignal TransductionSiteSkeletal MuscleSubstrate SpecificityTestingglucose disposalglucose transportglucose uptakehuman NOS2A proteinimprovedin vivoinhibitor/antagonistinnovationinsightinsulin sensitivityinsulin signalingnovelpreventprotein phosphatase 2A regulatory subunit 65 kDarab GTP-Binding Proteinsresearch studysedentary
项目摘要
DESCRIPTION (provided by applicant): Increased post-exercise (PEX) insulin sensitivity, first demonstrated in 1982, is among the best documented exercise benefits linked to improved health, but identification of the mechanism has been elusive. Exercise by lean, normal individuals has little effect on proximal insulin signaling, suggesting exercise alters a distal site. Progress stalled until the discovery of a sustained PEX increase in the most distal signaling step known to be crucial for glucose transport (GT): phosphorylation of Akt Substrate of 160 kDa (AS160). The sustained PEX increase in phosphorylated AS160 (pAS160) tracks closely with elevated insulin-induced GT in lean rats, and sustained pAS160 is also found in muscle of lean humans PEX. Increased pAS160 has emerged as an attractive candidate to explain improved insulin sensitivity PEX. The broad, long-term goal is to fully elucidate the mechanisms that underlie enhanced insulin sensitivity PEX. The 3 Specific Aims are: 1) Identify the mechanism for the sustained increase in AS160 phosphorylation in skeletal muscle of lean rats after exercise. 2) By expressing in rat skeletal muscle AS160 that is genetically modified to prevent phosphorylation on key sites, determine AS160's role in exercise-induced changes in GT in lean rats. 3) Identify the similarities and differences between lean and obese rats in the specific mechanisms for their respective exercise-induced improvements in insulin-stimulated GT. Evidence indicates the sustained PEX increase in pAS160 is not attributable to persistent activation of kinases. A novel idea to be tested is that the sustained elevation in pAS160 is because of attenuated AS160 dephosphorylation by Ser/Thr protein phosphatases. Because preliminary data implicate protein phosphatase 2A (PP2A) in AS160 dephosphorylation, multiple approaches will be used for Aim 1 to probe PP2A's regulation of pAS160. Aim 2 will use an innovative method to measure GT by single muscle fibers that are matched for fiber type, but differ by expression of wildtype AS160 or AS160 genetically modified to prevent phosphorylation on key sites to learn if the improved PEX insulin-mediated GT in lean rats is attributable to greater pAS160. Aim 3 will determine if the well-known exercise benefits on insulin sensitivity for lean and obese rats are accrued by distinct mechanisms. Exercise by obese rats is predicted to reduce high muscle levels of mediators of insulin resistance (inducible nitric oxide synthase; protein S- nitrosylation; lipid metabolites; JNK, IKK & PKC? activation) leading to enhanced insulin signaling and GT. However, in muscles from lean rats, exercise is predicted to not greatly alter their already low levels of mediators or normal levels of proximal insulin signaling. The sustained increase in pAS160 PEX observed in lean humans was reported to be less in obese people. Accordingly, experiments will be performed to test if the greater PEX insulin-mediated GT previously found for lean vs. obese rats is attributable to greater pAS160 PEX in lean rats. Completion of the proposed research will provide novel insights into the specific mechanisms that account for improved insulin sensitivity, a major health benefit for both lean and obese individuals.
描述(由申请人提供):运动后 (PEX) 胰岛素敏感性的增加于 1982 年首次得到证实,是与改善健康相关的最佳记录的运动益处之一,但其机制的识别一直难以捉摸。瘦弱的正常人的运动对近端胰岛素信号传导几乎没有影响,这表明运动会改变远端部位。进展陷入停滞,直到发现已知对葡萄糖转运 (GT) 至关重要的最远端信号传导步骤中的 PEX 持续增加:160 kDa 的 Akt 底物 (AS160) 磷酸化。磷酸化 AS160 (pAS160) 的持续 PEX 增加与瘦大鼠中胰岛素诱导的 GT 升高密切相关,并且在瘦人 PEX 的肌肉中也发现了持续的 pAS160。 pAS160 增加已成为解释胰岛素敏感性 PEX 改善的一个有吸引力的候选者。广泛的长期目标是充分阐明胰岛素敏感性 PEX 增强的机制。 3 个具体目标是: 1) 确定运动后瘦大鼠骨骼肌中 AS160 磷酸化持续增加的机制。 2) 通过在大鼠骨骼肌中表达 AS160(经过基因改造以防止关键位点磷酸化),确定 AS160 在运动引起的瘦大鼠 GT 变化中的作用。 3) 确定瘦大鼠和肥胖大鼠在运动诱导胰岛素刺激 GT 改善的具体机制方面的异同。有证据表明 pAS160 中 PEX 的持续增加并非归因于激酶的持续激活。一个待测试的新想法是 pAS160 持续升高是因为 Ser/Thr 蛋白磷酸酶减弱了 AS160 去磷酸化。由于初步数据表明蛋白磷酸酶 2A (PP2A) 参与 AS160 去磷酸化,因此目标 1 将使用多种方法来探测 PP2A 对 pAS160 的调节。目标 2 将使用一种创新方法,通过与纤维类型匹配的单根肌纤维来测量 GT,但野生型 AS160 或经过基因改造以防止关键位点磷酸化的 AS160 的表达有所不同,以了解瘦大鼠中 PEX 胰岛素介导的 GT 的改善是否归因于 pAS160 的增强。目标 3 将确定众所周知的运动对瘦大鼠和肥胖大鼠的胰岛素敏感性的益处是否是通过不同的机制产生的。肥胖大鼠的运动预计会降低肌肉中高水平的胰岛素抵抗介质(诱导型一氧化氮合酶;蛋白质 S-亚硝基化;脂质代谢物;JNK、IKK 和 PKC?激活),从而增强胰岛素信号传导和 GT。然而,在瘦大鼠的肌肉中,预计运动不会极大地改变它们已经很低的介质水平或近端胰岛素信号的正常水平。据报道,在瘦人中观察到的 pAS160 PEX 持续增加在肥胖人中较少。因此,将进行实验来测试先前在瘦大鼠与肥胖大鼠中发现的较高的PEX胰岛素介导的GT是否可归因于瘦大鼠中较高的pAS160 PEX。拟议研究的完成将为改善胰岛素敏感性的具体机制提供新的见解,这对瘦人和肥胖者来说都是一个主要的健康益处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory D. Cartee其他文献
Gregory D. Cartee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory D. Cartee', 18)}}的其他基金
Regulation of Elevated Postexercise Insulin-stimulated Glucose Uptake by Skeletal Muscle
运动后骨骼肌对胰岛素刺激的葡萄糖摄取升高的调节
- 批准号:
10834392 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
- 批准号:
8001325 - 财政年份:2010
- 资助金额:
$ 3.73万 - 项目类别:
Aging, Calorie Restriction and Insulin Signaling
衰老、热量限制和胰岛素信号传导
- 批准号:
7909218 - 财政年份:2009
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
- 批准号:
7429800 - 财政年份:2006
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
- 批准号:
7143435 - 财政年份:2006
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
- 批准号:
8775661 - 财政年份:2006
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
- 批准号:
7254719 - 财政年份:2006
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Transport: Exercise and Insulin
骨骼肌葡萄糖转运:运动和胰岛素
- 批准号:
8234373 - 财政年份:2006
- 资助金额:
$ 3.73万 - 项目类别:
Skeletal Muscle Glucose Uptake: Exercise and Insulin
骨骼肌葡萄糖摄取:运动和胰岛素
- 批准号:
9921359 - 财政年份:2006
- 资助金额:
$ 3.73万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 3.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 3.73万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 3.73万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 3.73万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 3.73万 - 项目类别:
Idea to Innovation














{{item.name}}会员




